Sangamo Therapeutics (SGMOQ) Goodwill (2013 - 2022)

Sangamo Therapeutics' Goodwill history runs 10 years deep, the most recent figure standing at $37.6 million for Q4 2022.

• On a quarterly basis, Goodwill fell 5.42% year-over-year to $37.6 million in Q4 2022; TTM through Dec 2022 was $37.6 million, a 5.42% decrease from a year earlier, with the FY2022 full-year figure at $37.6 million, down 5.42% from the prior year.
• Goodwill rose to $37.6 million in Q4 2022 per SGMOQ's latest filing, from $34.5 million in the prior quarter.
• Across five years, Goodwill topped out at $42.8 million in Q4 2020 and bottomed at $1.6 million in Q1 2018.
• The 5-year median for Goodwill is $39.3 million (2019), against an average of $33.7 million.
• Across the five-year window, Goodwill surged 2426.44% in 2018 and dropped 14.85% in 2022, its largest moves.
• Year by year, Goodwill stood at $40.0 million in 2018, then retreated by 1.93% to $39.3 million in 2019, then rose by 8.98% to $42.8 million in 2020, then decreased by 7.23% to $39.7 million in 2021, then decreased by 5.42% to $37.6 million in 2022.
• Per Business Quant, the three latest SGMOQ Goodwill figures stand at $37.6 million (Q4 2022), $34.5 million (Q3 2022), and $36.7 million (Q2 2022).